Download Results
1 research outcomes, page 1 of 1
  • publication . Article . 2019
    Open Access
    Colin Hessel; Michael J. Morris; Joel Picus; Darren R. Feldman; Daniel J. George; Toni K. Choueiri; Susan Halabi; Christian Scheffold; Shaker R. Dakhil; Olwen Hahn; ...
    Publisher: Wiley
    Project: NIH | Network Lead Academic Par... (3U10CA180791-04S1), NIH | Washington University/ Si... (5U10CA180833-05), NIH | OSU as Network Lead Acade... (1U10CA180850-01), NIH | Statistics and Data Cente... (5U10CA180882-02), NIH | Alliance for Clinical Tri... (3U10CA180821-02S2), NIH | NCI National Clinical Tri... (5U10CA180857-02), NIH | MOUSE GENETICS (2P30CA008748-43), NIH | NCTN Lead Academic Partic... (5U10CA180867-04)

    Abstract Cabozantinib treatment prolonged progression‐free survival (PFS) and improved objective response rate (ORR) compared with sunitinib in patients with advanced renal cell carcinoma (RCC) of intermediate or poor risk by International Metastatic Renal Cell Carcinom...

1 research outcomes, page 1 of 1